PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age2-16
SponsorPoznan University of Medical Sciences
About this trial
This randomized controlled trial (RCT) compares the analgesic effectiveness of two regional anesthesia techniques-Pericapsular Nerve Group (PENG) block combined with Lateral Femoral Cutaneous Nerve Block (LFCB) versus Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB and S-ESPB)-in pediatric patients undergoing hip surgery.
Eligibility criteria
Qualifiers
Pediatric patients aged between 2 and 16 years.
Scheduled for elective orthopedic hip surgery, including: Osteotomies and Hip reconstruction surgeries
ASA (American Society of Anesthesiologists) physical status classification: I-III.
Written informed consent obtained from the patient's legal guardian(s).
Disqualifiers
Known allergy or hypersensitivity to any of the study medications
Presence of infection or inflammation at the intended injection site(s) of regional anesthesia.
Coagulopathy or bleeding disorders (including patients on anticoagulant therapy) that contraindicate nerve blocks.
Neurological disorders or peripheral neuropathies that could influence sensory or motor assessment of the lower limbs.
Trial design
Treatments tested in this trial
- Ropivacaine 0.2% for PENG Block
- Ropivacaine 0.2% for LFCB
- Ropivacaine 0.2% for L-ESPB
- Ropivacaine 0.2% for S-ESPB
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov